本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Castle Biosciences, Inc.

14.65
-0.5000-3.30%
盤後14.650.00000.00%18:05 EDT
成交量:42.16萬
成交額:624.36萬
市值:4.23億
市盈率:-79.41
高:15.16
開:15.16
低:14.61
收:15.15
資料載入中...
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/13

SEC問詢函

Form CORRESP - Correspondence
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans